The significance of low PU.1 expression in patients with acute promyelocytic leukemia

Journal of Hematology and Oncology

Volumn 5, Issue , 2012, Pages

  Zhu, Xuehua ^a   Zhang, Hui ^a   Qian, Maoxiang ^a   Zhao, Xujie ^a   Yang, Wentao ^a   Wang, Ping ^a   Zhang, Ji ^a   Wang, Kankan ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Acute promyelocytic leukemia; PML RAR; PU.1

Indexed keywords

RETINOIC ACID RECEPTOR ALPHA; TRANSCRIPTION FACTOR PU 1;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CELL POPULATION; CLINICAL ARTICLE; FEMALE; GRANULOCYTE; HEMATOPOIETIC CELL; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LEUKOCYTE; MALE; MONONUCLEAR CELL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; DISEASE PROGRESSION; FEMALE; FETAL BLOOD; GENE EXPRESSION PROFILING; HUMANS; LEUKEMIA, MYELOID, ACUTE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, FUSION; PROGNOSIS; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84860606995     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-5-22     Document Type: Article

References (25)

1. Acute promyelocytic leukemia: from highly fatal to highly curable. Wang ZY, Chen Z, Blood 2008 111 2505 2515 10.1182/blood-2007-07-102798 18299451
2. Role of PML in cell growth and the retinoic acid pathway. Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C, Grosveld F, Pandolfi PP, Science 1998 279 1547 1551 10.1126/science.279.5356.1547 9488655 (Pubitemid 28217080)
3. Function of RARalpha during the maturation of neutrophils. Kastner P, Chan S, Oncogene 2001 20 7178 7185 10.1038/sj.onc.1204757 11704846 (Pubitemid 33105007)
4. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences. Grisolano JL, Wesselschmidt RL, Pelicci PG, Ley TJ, Blood 1997 89 376 387 9002938 (Pubitemid 27051671)
5. PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia. Wang K, Wang P, Shi J, Zhu X, He M, Jia X, Yang X, Qiu F, Jin W, Qian M, Fang H, Mi J, Yang X, Xiao H, Minden M, Du Y, Chen Z, Zhang J, Cancer Cell 2010 17 186 197 10.1016/j.ccr.2009.12.045 20159610
6. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression. Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG, Blood 2006 107 3330 3338 10.1182/blood-2005-07-3068 16352814
7. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC, J Exp Med 1996 183 1797 1806 10.1084/jem.183.4.1797 8666936 (Pubitemid 26134320)
8. Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia. Gutierrez NC, Lopez-Perez R, Hernandez JM, Isidro I, Gonzalez B, Delgado M, Ferminan E, Garcia JL, Vazquez L, Gonzalez M, San Miguel JF, Leukemia 2005 19 402 409 10.1038/sj.leu.2403625 15674361 (Pubitemid 40403317)
9. Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia. Tomasson MH, Xiang Z, Walgren R, Zhao Y, Kasai Y, Miner T, Ries RE, Lubman O, Fremont DH, McLellan MD, Payton JE, Westervelt P, DiPersio JF, Link DC, Walter MJ, Graubert TA, Watson M, Baty J, Heath S, Shannon WD, Nagarajan R, Bloomfield CD, Mardis ER, Wilson RK, Ley TJ, Blood 2008 111 4797 4808 10.1182/blood-2007-09-113027 18270328
10. Prognostically useful gene-expression profiles in acute myeloid leukemia. Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Boer JM, Beverloo HB, Moorhouse MJ, van der Spek PJ, Lowenberg B, Delwel R, N Engl J Med 2004 350 1617 1628 10.1056/NEJMoa040465 15084694 (Pubitemid 38528701)
11. Gene expression profiling of pediatric acute myelogenous leukemia. Ross ME, Mahfouz R, Onciu M, Liu HC, Zhou X, Song G, Shurtleff SA, Pounds S, Cheng C, Ma J, Ribeiro RC, Rubnitz JE, Girtman K, Williams WK, Raimondi SC, Liang DC, Shih LY, Pui CH, Downing JR, Blood 2004 104 3679 3687 10.1182/blood-2004-03-1154 15226186 (Pubitemid 39564445)
12. The importance of PU.1 concentration in hematopoietic lineage commitment and maturation. Dahl R, Simon MC, Blood Cells Mol Dis 2003 31 229 233 10.1016/S1079-9796(03)00152-9 12972030
13. A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements. Group Francais de Cytogenetique Hematologique, UK Cancer Cytogenetics Group and BIOMED 1 European Coomunity-Concerted Acion "Molecular Cytogenetic Diagnosis in Haematological Malignancies. Sainty D, Liso V, Cantu-Rajnoldi A, Head D, Mozziconacci MJ, Arnoulet C, Benattar L, Fenu S, Mancini M, Duchayne E, Mahon FX, Gutierrez N, Birg F, Biondi A, Grimwade D, Lafage-Pochitaloff M, Hagemeijer A, Flandrin G, Blood 2000 96 1287 1296 10942370
14. Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cells. Zheng X, Seshire A, Ruster B, Bug G, Beissert T, Puccetti E, Hoelzer D, Henschler R, Ruthardt M, Haematologica 2007 92 323 331 10.3324/haematol.10541 17339181 (Pubitemid 350143541)
15. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Parmar K, Mauch P, Vergilio JA, Sackstein R, Down JD, Proc Natl Acad Sci U S A 2007 104 5431 5436 10.1073/pnas.0701152104 17374716 (Pubitemid 47175697)
16. Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors. Nutt SL, Metcalf D, D'Amico A, Polli M, Wu L, J Exp Med 2005 201 221 231 10.1084/jem.20041535 15657291 (Pubitemid 40189431)
17. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Rosenbauer F, Wagner K, Kutok JL, Iwasaki H, Le Beau MM, Okuno Y, Akashi K, Fiering S, Tenen DG, Nat Genet 2004 36 624 630 10.1038/ng1361 15146183 (Pubitemid 38715991)
18. Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia. Metcalf D, Dakic A, Mifsud S, Di RL, Wu L, Nutt S, Proc Natl Acad Sci U S A 2006 103 1486 1491 10.1073/pnas.0510616103 16432184 (Pubitemid 43191192)
19. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia. Vangala RK, Heiss-Neumann MS, Rangatia JS, Singh SM, Schoch C, Tenen DG, Hiddemann W, Behre G, Blood 2003 101 270 277 10.1182/blood-2002-04-1288 12393465 (Pubitemid 36025918)
20. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias. Lo CF, Pisegna S, Diverio D, Haematologica 1997 82 364 370 9234595 (Pubitemid 28023324)
21. Mouse models of acute promyelocytic leukemia. Pollock JL, Westervelt P, Walter MJ, Lane AA, Ley TJ, Curr Opin Hematol 2001 8 206 211 10.1097/00062752-200107000-00005 11561157 (Pubitemid 32762962)
22. Oncogenic K-ras cooperates with PML-RAR alpha to induce an acute promyelocytic leukemia-like disease. Chan IT, Kutok JL, Williams IR, Cohen S, Moore S, Shigematsu H, Ley TJ, Akashi K, Le Beau MM, Gilliland DG, Blood 2006 108 1708 1715 10.1182/blood-2006-04-015040 16675706 (Pubitemid 44316141)
23. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model. Kelly LM, Kutok JL, Williams IR, Boulton CL, Amaral SM, Curley DP, Ley TJ, Gilliland DG, Proc Natl Acad Sci U S A 2002 99 8283 8288 10.1073/pnas.122233699 12060771 (Pubitemid 34651044)
24. BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia. Kogan SC, Brown DE, Shultz DB, Truong BT, Lallemand-Breitenbach V, Guillemin MC, Lagasse E, Weissman IL, Bishop JM, J Exp Med 2001 193 531 543 10.1084/jem.193.4.531 11181704 (Pubitemid 32524483)
25. Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha. Walter MJ, Park JS, Ries RE, Lau SK, McLellan M, Jaeger S, Wilson RK, Mardis ER, Ley TJ, Proc Natl Acad Sci U S A 2005 102 12513 12518 10.1073/pnas.0504247102 16113082 (Pubitemid 41266390)